DRI officials seize 119.4 kg of Alprazolam worth Rs. 23.88 crore

New Delhi:  The officers of Directorate of Revenue Intelligence from Hyderabad, Visakhapatnam, Vijayawada and Kakinada executed a swift and well-coordinated operation resulting in seizure of 119.4 kg Alprazolam in lumpy form, valued at approximately Rs. 23.88 crore in the illicit market, along with 87.8 kg in-process material. The DRI officials also apprehended eight persons involved in illegal manufacturing and distribution of Alprazolam, including the master-mind, chemists, financiers and the buyers at the same place.

After developing a specific intelligence that a few persons were clandestinely manufacturing ‘Alprazolam’ — a psychotropic substance under the NDPS Act, 1985 — at a facility in Atchutapuram, Anakapalli District, Andhra Pradesh, the DRI officials meticulously planned the operation to arrest the entire set of persons involved in manufacturing and distribution of Alprazolam.

Additionally, 3,600 litres in liquid form and 311.6 kg in solid form of illegally procured raw materials, equipment (two reactors, one centrifuge and one drier) used for manufacturing Alprazolam and few incriminating documents were seized to aid further investigation.

All the eight accused persons were arrested and remanded to judicial custody. It is noteworthy that most of the arrested individuals have prior involvement in cases related to the clandestine manufacture of narcotic drugs and psychotropic substances and other criminal activities (murder, cyber-crimes and economic offences).

Initial interrogation revealed that these individuals conspired to undertake this illegal activity, having formed their network during their time in jail, underscoring the deep-rooted and organized nature of the syndicate. The said Alprazolam was intended for transport to Telangana for adulterating Toddy.

Further investigation in the case is in progress.

Related Posts

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week. Argentina has committed to reduce barriers to facilitate the entry of…

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

The regulator had found that medicines were stored directly on the floor and flagged deficiencies in procedures for handling expired medicines.   The Maharashtra Food and Drug Administration has cancelled…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

Six fake doctors arrested in Hyderabad

Six fake doctors arrested in Hyderabad